期刊文献+

乳腺癌术后吡柔比星或阿霉素为主两种化疗方案的临床疗效分析 被引量:9

Chemotherapy with THP-containing regimen or ADM-containing regimen for the treatment of breast cancer after operation
在线阅读 下载PDF
导出
摘要 目的 对比乳腺癌术后以THP为主及ADM为主的两种化疗方案的疗效及毒副反应。方法 72例Ⅱ、Ⅲ期乳腺癌术后患者中42例用CTF方案(CTX+THF+5-Fu)化疗6个疗程,30例用CAF方案(CTX+ADM+5-Fu)化疗6个疗程,观察这两种方案的毒副反应及疗效。结果 THP组白细胞减少发生率为47.6%,心电图异常发生率4.8%,脱发发生率33.3%,胃肠反应发生率33.3%:ADM组白细胞减少发生率为76.7%,心电图异常发生率20.0%,脱发发生率100.0%,胃肠反应发生率56.7%。结论 CTF方案是乳腺癌术后理想的化疗方案,其疗效与CAF方案相当,但其毒副反应较轻,特别是白细胞减少、心脏毒性及脱发作用较小。毒副反应轻可减少患者对化疗的恐惧情绪,提高患者的生活质量。 Objective To evaluate the efficacy and toxicity of THP-containing regimen or ADM-containing regimen in the treatment of breast cancer after operation. Method Seventy-two cases were stageⅡ -Ⅲ breast cancer after operation. Forth-two cases were treated by THP-containing regimen for 6 cycles,and 30 cases were treated by ADM-containing regimen for 6 cycles.Results THP-containing regimen:The rate of leukopenia was 47.6% , cardiac toxicity 4.8% .alopecia 33.3% ,nausea and vomiting 33.3% .ADM-containing regimem: The rate of leukopenia was 76.7% ,cardiac toxicity 20.0% , alopecia 100.0% , nausea and vomiting 56.7% . Conclusion Compared with ADM-containing regimen, THP-containing regimen is an effective and lower toxicity chemotherapy for breast cancer after operation, specially lower cardiac toxicity leakopenia and alopecia. The lower toxicity can diminish patient afraid of chemotherapy. It is benefit for the quality of life(QOL) of patient.
出处 《中国肿瘤临床与康复》 2004年第1期45-46,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 乳腺肿瘤 化学疗法 吡柔比星 阿霉素 化疗方案 疗效 毒副反应 术后 Breast neoplasm/chemotherapy Pirarubicin ADM
  • 相关文献

参考文献3

二级参考文献11

  • 1赖清宏.以华明产阿霉素为主联合化疗9425例恶性肿瘤临床疗效综合分析[J].中国肿瘤临床,1993,20(4):288-292. 被引量:8
  • 2崔秀珍,葛正津.吡柔比星和阿霉素的临床观察对比[J].中国肿瘤临床,1994,21(9):642-644. 被引量:31
  • 3蔡浩 应倩 等.吡喃阿霉素(THP)联药治疗癌瘤219例的近期疗效观察[J].中国肿瘤临床,1995,22:257-257.
  • 4王肇炎,,阿霉素的临床应用,1991年,1页
  • 5潘启超,肿瘤药理及化学治疗,1989年,14页
  • 6孙燕,肿瘤化学治疗新进展,1987年,146页
  • 72,Blumenschein GR,Cardenas JO,Freireich EJ,et al.FAC combination chemotherapy formetastatic breast cancer.Proc Am Assoc Cancer Res 1974;15:193
  • 83,Tatuo S,Yoichi K,Akira W,et al.Multi-institutional cooperative study.Phase Ⅱ studyof (2″ R)-4-O-tetrahy dropyranyladriamycin(THP) in patients with solid tumors.Jpn JCancer Chemother.1986;13(4):1060
  • 96,Diaz-canton EA,Valero V,Rahman Z,et al.Clinical course of breast cancer patients withmetastases confined to the lungs treated with chemotherapy.ANN Oncol.1998;9(4):413
  • 10孙燕.乳腺癌的内科治疗[J].现代诊断与治疗,1998,9(4):193-197. 被引量:13

共引文献15

同被引文献121

引证文献9

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部